Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
77.50
+1.77 (2.34%)
At close: Oct 17, 2025, 4:00 PM EDT
77.50
0.00 (0.00%)
Pre-market: Oct 20, 2025, 7:04 AM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $4.82 billion as of October 20, 2025. Its market cap has increased by 81.97% in one year.
Market Cap
4.82B
Enterprise Value
4.16B
1-Year Change
81.97%
Ranking
Category
Stock Price
$77.50
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $4.82B, an increase of 2,711.30%. That is a compound annual growth rate of 43.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 4.82B | 109.58% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.58B |
| Johnson & Johnson | 464.95B |
| AbbVie | 406.57B |
| UnitedHealth Group | 321.42B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.83B |